Related references
Note: Only part of the references are listed.Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy
Sohail Rao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Outbreak of endemic carbapenem-resistant Acinetobacter baumannii in a coronavirus disease 2019 (COVID-19)-specific intensive care unit
Danielle Rosani Shinohara et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)
Impact of carbapenem-resistant Acinetobacter baumannii infections on acute pancreatitis patients
Di Wu et al.
PANCREATOLOGY (2022)
Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece
Dimitra Petropoulou et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region
Sabrina Cherubini et al.
DIAGNOSTICS (2022)
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit
Alessandro Russo et al.
INFECTION (2022)
Risk of community- and hospital-acquired bacteremia and profile of antibiotic resistance in children hospitalized with severe acute malnutrition in Niger
Christopher T. Andersen et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)
Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia
Alexandre Elabbadi et al.
INFECTION (2021)
Cerebrospinal fluid (CSF) augments metabolism and virulence expression factors in Acinetobacter baumannii
Jasmine Martinez et al.
SCIENTIFIC REPORTS (2021)
Microbial Distribution and Antibiotic Susceptibility of Bloodstream Infections in Different Intensive Care Units
Nan Duan et al.
FRONTIERS IN MICROBIOLOGY (2021)
Phenotypic and molecular characterizations of carbapenem-resistant Acinetobacter baumannii isolates collected within the EURECA study
T. Kostyanev et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Giuseppe Mancuso et al.
PATHOGENS (2021)
Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
Adam B. Shapiro et al.
FRONTIERS IN MICROBIOLOGY (2021)
The abaI/abaR Quorum Sensing System Effects on Pathogenicity in Acinetobacter baumannii
Xiaoyu Sun et al.
FRONTIERS IN MICROBIOLOGY (2021)
Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan
Noor Andryan Ilsan et al.
MICROORGANISMS (2021)
Whole-Genome Sequencing (WGS) of Carbapenem-Resistant K. pneumoniae Isolated in Long-Term Care Facilities in the Northern Italian Region
Alessandra Piccirilli et al.
MICROORGANISMS (2021)
Acinetobacter baumannii Infections in Times of COVID-19 Pandemic
Karyne Rangel et al.
PATHOGENS (2021)
Molecular Characterization of German Acinetobacter baumannii Isolates and Multilocus Sequence Typing (MLST) Analysis Based on WGS Reveals Novel STs
Gamal Wareth et al.
PATHOGENS (2021)
Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: a case report
Ancong Xu et al.
BMC INFECTIOUS DISEASES (2020)
Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary university hospital of Verona (northern Italy): co-production of KPC-3, OXA-48, and CTX-M-15 beta-lactamases
Alessandra Piccirilli et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Detection of Antimicrobial Resistance Genes Associated with Carbapenem Resistance from the Whole-Genome Sequence of Acinetobacter baumannii Isolates from Malaysia
Mohan Rao et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2020)
Antimicrobial Resistance in ESKAPE Pathogens
David M. P. De Oliveira et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance
Seyyed Naser Abdi et al.
INFECTION AND DRUG RESISTANCE (2020)
Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
Maria Soledad Ramirez et al.
BIOMOLECULES (2020)
Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam
Gamal Wareth et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Bacterial co-infections withSARS-CoV-2
Rasoul Mirzaei et al.
IUBMB LIFE (2020)
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Rosalino Vazquez-Lopez et al.
ANTIBIOTICS-BASEL (2020)
Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolates Belonging to Major Endemic Clones in South America
Carolina Silva Nodari et al.
FRONTIERS IN MICROBIOLOGY (2020)
An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1
Candace M. Marr et al.
FRONTIERS IN MICROBIOLOGY (2020)
Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania
Happiness H. Kumburu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation
Cheng-Hong Yang et al.
MOLECULES (2019)
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mansura S. Mulani et al.
FRONTIERS IN MICROBIOLOGY (2019)
The role of Acinetobacter baumannii response regulator BfmR in pellicle formation and competitiveness via contact-dependent inhibition system
Renatas Krasauskas et al.
BMC MICROBIOLOGY (2019)
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
Krystyna M. Kazmierczak et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Over-Expression of ISAba1-Linked Intrinsic and Exogenously Acquired OXA Type Carbapenem-Hydrolyzing-Class D-ß-Lactamase-Encoding Genes Is Key Mechanism Underlying Carbapenem Resistance in Acinetobacter baumannii
Marcus Ho-yin Wong et al.
FRONTIERS IN MICROBIOLOGY (2019)
Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-econtrol study
Chung-Ting Chen et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2018)
Uncovering the mechanisms of Acinetobacter baumannii virulence
Christian M. Harding et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru
Saul Levy-Blitchteini et al.
EMERGING MICROBES & INFECTIONS (2018)
Mobile Genetic Elements Associated with Antimicrobial Resistance
Sally R. Partridge et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
Muhammad Asif et al.
INFECTION AND DRUG RESISTANCE (2018)
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Darren Wong et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
The effect of ISAba1-mediated adeN gene disruption on Acinetobacter baumannii pathogenesis
Man Hwan Oh et al.
VIRULENCE (2017)
Colistin-resistant Acinetobacter baumannii ventilator-associated pneumonia in a tertiary care hospital: an evolving threat
M. Gupta et al.
JOURNAL OF HOSPITAL INFECTION (2016)
The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity
Cynthia M. June et al.
PROTEIN SCIENCE (2016)
Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data
O. Oikonomou et al.
BMC INFECTIOUS DISEASES (2015)
RND-Type Efflux Pumps in Multidrug-Resistant Clinical Isolates of Acinetobacter baumannii: Major Role for AdeABC Overexpression and AdeRS Mutations
Eun-Jeong Yoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp.
Sebastien Coyne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme
A. Di Popolo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Genetic analysis of surface motility in Acinetobacter baumannii
Katy M. Clemmer et al.
MICROBIOLOGY-SGM (2011)
Analysis of antibiotic resistance regions in Gram-negative bacteria
Sally R. Partridge
FEMS MICROBIOLOGY REVIEWS (2011)
Diversity, Epidemiology, and Genetics of Class D beta-Lactamases
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii
Stephane Corvec et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
JF Turton et al.
FEMS MICROBIOLOGY LETTERS (2006)
AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains
S Corvec et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Share Paper
